FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0549 | 71283-0549-2 | Alprostadil; Papaverine Hydrochloride; Atropine Sulfate; Phentolamine Mesylate | 40 ug/1 mL; 25 mg/1 mL; .01 mg/1 mL; .5 mg/1 mL | 2020-1 | valid | 2026-10-13 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0549 | 71283-0549-2 | Alprostadil; Papaverine Hydrochloride; Atropine Sulfate; Phentolamine Mesylate | 40 ug/1 mL; 25 mg/1 mL; .01 mg/1 mL; .5 mg/1 mL | 2019-1 | valid | 2026-10-13 |